Interventional Pulmonology Market By Procedure (Flexible Bronchoscopy, Rigid Bronchoscopy, Bronchoalveolar Lavage, Lung Biopsy, Bronchial Stent, Balloon Bronchoplasty, Pleuroscopy and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

The interventional pulmonology market is set to reach from US$ 1,145.6 Mn in 2017 to US$ 1,747.0 Mn by 2026 highlighting unswerving growth at a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), in 2018 approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading causes of formation of malignant tumours and neoplasms in the lungs. Interventional pulmonology is a relatively new field which has gained tremendous attraction in the last decade which employs sophisticated tools to perform diagnosis and treatment of various pulmonary disorders. Apart from pulmonologist cardiothoracic surgeons also routinely perform interventional pulmonology procedures.

Market Synopsis

Get a sample copy for more information

"Accurate diagnosis, precise sample collection and increasing number of lung complications drive the flexible bronchoscopy market growth"

Flexible bronchoscopy is dominating the procedure type segment for interventional pulmonology market. Flexible bronchoscopy is useful in diagnosing different stages of lung cancer, palliative care by debulking endobronchial lesions and treating in airway stenosis. Its inherent features such as accurate diagnosis, precise sample collection and significant rise in lung complication together drive the flexible bronchoscopy market growth. Pleuroscopy is gaining huge demand as an alternative to video assisted thoracoscopic surgery (VATS) which is employed for the diagnosis of pleural effusion of unknown etiology. It is a minimally invasive surgical procedure and has successfully achieved 100% accurate diagnosis of tuberculous effusion. It is relatively well tolerated procedure with negligible complications.

Get a sample copy for more information

"Rising prevalence of lung cancer and growing health awareness together drive the market growth in North America"

In the current scenario North America is dominating the regional segment for interventional pulmonology market. The factors responsible for its market share of 35% are rising prevalence of lung cancer and growing health awareness. According to American Lung Association (ALA) in 2018, 234,030 new cases of lung cancer were diagnosed in the United States which represents 13% of all diagnosed cancer. Europe holds 30% market share owing to the significant rise in air pollution and tobacco smoking. Stringent norms related to early diagnosis and medical intervention drive the interventional pulmonology market growth in European region. Asia Pacific is representing 15% market share on account of increasing establishment of subsidiaries and retail outlets of major players such as Boston Scientific Corporation, Karl Storz, Medtronic, Plc., and Terumo Corporation etc. Supportive regulatory environment provided by regional healthcare bodies further bolster the market growth in Asia Pacific region.

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by procedure and by geography. 

Medical device companies competing in interventional pulmonology market are Boston Scientific Corporation, BTG, Plc., Ethicon, Inc., ENDO-FLEX GmbH, HealthTronics, Inc., Karl Storz, Medtronic, Plc., Pulmonx, Inc., Terumo Corporation and Varian Medical Systems, Inc.

Key questions answered in this report

• What are the organic and inorganic market growth strategies associated with interventional pulmonology market?
• Which medical device manufactures are associated with interventional pulmonology market?
• What is the disease etiology associated with different kinds of pulmonary disorders?
• What is pleuroscopy and how will it perform during the forecast period from 2018 to 2026?
• What is the prevalence rate of lung cancer and Asia Pacific region and how will it respond to existing market trends in interventional pulmonology market?

Chapter 1. Preface
1.1. Report Scope and Descrtion
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Procedure
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global IP Market Portraiture
2.2. Global IP Market, by Procedure, 2017 (US$ Mn)
2.3. Global IP Market, by Geography, 2017 (US$ Mn)

Chapter 3. Interventional Pulmonology (IP) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IP Market, by Key Players, 2017

Chapter 4. Global Interventional Pulmonology (IP) Market, by Procedure
4.1. Overview
4.2. Flexible Bronchoscopy
4.3. Rigid Bronchoscopy
4.4. Bronchoalveolar Lavage
4.5. Lung Biopsy
4.6. Bronchial Stent
4.7. Balloon Bronchoplasty
4.8. Pleuroscopy
4.9. Others

Chapter 5. Global Interventional Pulmonology (IP) Market, by Geography
5.1. Overview
5.2. North America IP Market Analysis, 2016 – 2026
5.2.1. North America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.2.2. North America IP Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe IP Market Analysis, 2016 – 2026
5.3.1. Europe IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.3.2. Europe IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific IP Market Analysis, 2016 – 2026
5.4.1. Asia Pacific IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America IP Market Analysis, 2016 – 2026
5.5.1. Latin America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.5.2. Latin America IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa IP Market Analysis, 2016 – 2026
5.6.1. MEA IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.6.2. MEA IP Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Boston Scientific Corporation
6.1.1. Business Descrtion
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. BTG, plc.
6.3. Ethicon, Inc.
6.4. ENDO-FLEX GmbH.
6.5. HealthTronics, Inc.
6.6. Karl Storz
6.7. Medtronic, plc.
6.8. Pulmonx, Inc.
6.9. Terumo Corporation
6.10. Varian Medical Systems, Inc.

* IP - Interventional Pulmonology

FIG. 1 Interventional Pulmonology (IP) Market: Research Methodology
FIG. 2 IP: Market Segmentation
FIG. 3 Global IP Market, by Procedure, 2017 (US$ Mn)
FIG. 4 Global IP Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global IP Market, by Key Players, 2017
FIG. 7 Global Flexible Bronchoscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 8 Global Rigid Bronchoscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 9 Global Bronchoalveolar Lavage Market for IP, 2016 – 2026 (US$ Mn)
FIG. 10 Global Lung Biopsy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 11 Global Bronchial Stent Market for IP, 2016 – 2026 (US$ Mn)
FIG. 12 Global Balloon Bronchoplasty Market for IP, 2016 – 2026 (US$ Mn)
FIG. 13 Global Pleuroscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 14 Global Other Procedures Market for IP, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. IP Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada IP Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. IP Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany IP Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe IP Market, 2016 – 2026 (US$ Mn)
FIG. 20 China IP Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan IP Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific IP Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil IP Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico IP Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America IP Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC IP Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of Middle East and Africa IP Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Interventional Pulmonology (IP) Market Portraiture
TABLE 2 Global IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 3 Global IP Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 5 North America IP Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 Europe IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 7 Europe IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 Asia Pacific IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Latin America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Middle East and Africa IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa IP Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 BTG, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Ethicon, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 ENDO-FLEX GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 HealthTronics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Karl Storz: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Pulmonx, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Varian Medical Systems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)